Bausch & Lomb to acquire Ista Pharmaceuticals for $500 million

27 Mar 2012

1

Bausch & Lomb, the maker of contact lenses yesterday said that it will buy eye care company Ista Pharmaceuticals Inc, for about $500 million in cash, in order to broaden its portfolio of eye health products.

The deal comes a month after Canada's Valeant Pharmaceuticals International withdrew its $7.50 a share or $327 million sweetened bid for Ista, citing lack of progress on the deal.

Rochester, New York-based Bausch & Lomb will pay $9.10 a share in cash, a premium of 10 per cent to Ista's closing price on 23 March, and a 40 per cent premium to Valeant's last month offer.

Irvine, California-based Ista is the third-largest branded prescription eye care company in the US with an expanding focus on allergy therapeutics.

Ista currently markets four products, including treatments for ocular inflammation and post-cataract surgery pain, glaucoma and ocular itching associated with allergic conjunctivitis.

The company, which generated revenues of $160 million in 2011, also has drugs in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more